Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 8, 2014, Pages 875-881

  Nery, Pablo B ^a   Beanlands, Rob S ^a   Nair, Girish M ^a   Green, Martin ^a   Yang, Jim ^a   McArdle, Brian A ^a   Davis, Darryl ^a   Ohira, Hiroshi ^a   Gollob, Michael H ^a   Leung, Eugene ^b   Healey, Jeff S ^c   Birnie, David H ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

atrioventricular block; cardiac sarcoidosis; implantable cardioverter defibrillator; middle aged; outcomes; pacing; prevalence; ventricular tachycardia

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ATRIOVENTRICULAR BLOCK; BIOPSY; CANADA; CARDIOMYOPATHIES; CARDIOVERSION; COMPUTER ASSISTED TOMOGRAPHY; DEVICES; DIAGNOSTIC USE; DISEASE FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR; TIME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ATRIOVENTRICULAR BLOCK; BIOPSY; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HEART FAILURE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ONTARIO; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECURRENCE; RISK FACTORS; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84905828264     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12401     Document Type: Article

References (30)

1. Barra SN, Providencia R, Paiva L, Nascimento J, Marques AL,: A review on advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 2012; 35: 1395-1405.
2. Kandolin R, Lehtonen J, Kupari M,: Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011; 4: 303-309.
3. Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI,: Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010; 19: 4100-4111.
4. Spagnolo P, du Bois RM,: Genetics of sarcoidosis. Clin Dermatol 2007; 25: 242-249.
5. Nery PB, Mc Ardle BA, Redpath CJ, Beanlands RS, Birnie DH,: Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2014; 37: 364-74. doi: 10.1111/pace.12277.
6. Kavanagh T, Huang S,: Cardiac sarcoidosis: An unforeseen cause of sudden death. Can J Cardiol 1995; 11: 136-138.
7. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK,: The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 1999; 78: 270-283.
8. Donsky AS, Escobar J, Capehart J, Roberts WC,: Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol 2002; 89: 1447-1450.
9. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG,: Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006; 3: 924-929.
10. Doughan AR, Williams BR,: Cardiac sarcoidosis. Heart 2006; 92: 282-288.
11. Fawcett FJ, Goldberg MJ,: Heart block resulting from myocardial sarcoidosis. Br Heart J 1974; 36: 220-223.
12. Rajani R, Prasad S, O'Nunain S, Sohal M, Ghuran A,: Heart block: A primary manifestation of sarcoidosis. Europace 2010; 12: 284-288.
13. Ramachandran V, Stevens MP, Amin M, Appleton D, Abbate A,: Bi-fascicular block on EKG as the initial presenting sign of cardiac sarcoidosis. Int J Cardiol 2007; 118: e1-e2.
14. Ruiz-Arango A, Sharma GK,: Exercise intolerance and multiple conduction abnormalities as first manifestation of cardiac sarcoidosis. South Med J 2008; 101: 1059-1061.
15. Yoshida Y, Morimoto S, Hiramitsu S, Tsuboi N, Hirayama H, Itoh T,: Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134: 382-386.
16. Mc Ardle BA, Birnie DH, Klein R, de Kemp RA, Leung E, Renaud J, DaSilva J, Wells GA, Beanlands RS, Nery PB,: Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18f- fluorodeoxyglucose positron emission tomography ? Circ Cardiovasc Imaging 2013; 6: 617-626.
17. Nery PB, Keren A, Healey J, Leug E, Beanlands RS, Birnie DH,: Isolated cardiac sarcoidosis: Establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol 2012; 29: 1015e1-1015e3.
18. Soejima K, Yada H,: The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: With emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009; 20: 578-583.
19. Cooper LT Jr, Blauwet LA,: When should high-grade heart block trigger a search for a treatable cardiomyopathy ? Circ Arrhythm Electrophysiol 2011; 4: 260-261.
20. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, Ogo KO, Nishii N, Watanabe A, Nagase S, Sakuragi S, Ohe T,: Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 1292-1299.
21. Furushima H, Chinushi M, Sugiura H, Kasai H, Washizuka T, Aizawa Y,: Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome. Clin Cardiol 2004; 27: 217-222.
22. Redheuil AB, Paziaud O, Mousseaux E,: Ventricular tachycardia and cardiac sarcoidosis: Correspondence between MRI and electrophysiology. Eur Heart J 2006; 27: 1430.
23. Britton KA, Stevenson WG, Levy BD, Katz JT, Loscalzo J,: Clinical problem-solving. The beat goes on. N Engl J Med 2010; 362: 1721-1726.
24. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A,: Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009; 104: 571-577.
25. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO,: 2012 ACCF/AHA/HRS Focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2013; 127: e283-352.
26. Mohsen A, Jimenez A, Hood RE, Dickfeld T, Saliaris A, Shorofsky S, Saba MM,: Cardiac sarcoidosis: Electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol 2013; 24:doi: 10.1111/jce.12302.
27. Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA,: Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 2013; 15: 347-354.
28. Ayyala US, Nair AP, Padilla ML,: Cardiac sarcoidosis. Clin Chest Med 2008; 29: 493-508.
29. Sadek M, Yung D, Birnie DH, Beanlands RS, Nery PB,: Corticosteroid therapy for cardiac sarcoidosis: A systematic review. Can J Cardiol 2013; 29: 1034-1041.
30. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivistö SM, Kupari M,: Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461-468.